Paul V. Maier, Director at Eton Pharmaceuticals, Inc. (ETON), bought 5,000 shares at $6.00 ($30K) on 2018-11-15, disclosed to the SEC on 2018-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |
| SQNM | BUY | 2012-08-02 | $27K | — | Filing → |